ZENO (Zenosense, Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

ZENO does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ZENO and 80,000+ other tickers.
See exactly how ZENO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ZENO and 80,000+ other tickers.
Presently, Zenosense, Inc. does not conduct substantial business activities. While it previously operated within the healthcare technology sector, the company is now focused on discovering and evaluating potential business ventures. Its strategic objective is to acquire an enterprise through mechanisms such as a reverse merger, an asset purchase, or other comparable transactions. Established in 2008, the entity was originally known as Braeden Valley Mines, Inc. until its rebranding as Zenosense, Inc. in November 2013. The company's principal office is situated in New York, New York.
No recent news available.